Basilea Pharmaceutica (BPMUF) Short Interest Ratio & Short Volume $47.50 0.00 (0.00%) As of 04/24/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Basilea Pharmaceutica Short Interest DataBasilea Pharmaceutica (BPMUF) has a short interest of 100 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a -95.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 55 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest2,100 sharesChange Vs. Previous Month-95.24%Dollar Volume Sold Short$5,400.00Short Interest Ratio1.0 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares13,170,000 sharesShort Percent of Float0.00%Today's Trading Volume0 sharesAverage Trading Volume55 sharesToday's Volume Vs. Average0% Short Selling Basilea Pharmaceutica? Sign up to receive the latest short interest report for Basilea Pharmaceutica and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBPMUF Short Interest Over TimeBPMUF Days to Cover Over TimeBPMUF Percentage of Float Shorted Over Time Basilea Pharmaceutica Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025100 shares $5,400.00 -95.2%0.0%1 $54.00 3/15/20252,100 shares $110,943.00 -86.6%0.0%21 $52.83 2/28/202515,700 shares $829,431.00 -29.0%0.1%0 $52.83 2/15/202522,100 shares $1.17 million No Change0.2%0 $52.83 1/31/202522,100 shares $1.17 million +34.8%N/A0 $52.83 1/15/202516,400 shares $866,412.00 No ChangeN/A0 $52.83 12/31/202416,400 shares $866,412.00 -34.4%N/A0 $52.83 12/15/202425,000 shares $1.32 million -11.0%N/A0 $52.83 11/30/202428,100 shares $1.48 million +5.2%N/A0 $52.83 11/15/202426,700 shares $1.41 million -11.3%N/A0 $52.83 Get the Latest News and Ratings for BPMUF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Basilea Pharmaceutica and its competitors with MarketBeat's FREE daily newsletter. 10/31/202430,100 shares $1.59 million -1.0%N/A0 $52.83 10/15/202430,400 shares $1.61 million -0.3%N/A304 $52.83 9/30/202430,500 shares $1.56 million -2.2%N/A305 $51.26 9/15/202431,200 shares $1.60 million No ChangeN/A0 $51.26 8/31/202431,200 shares $1.60 million +0.3%N/A0 $51.26 8/15/202431,100 shares $1.46 million -57.0%N/A0 $47.00 7/31/202472,300 shares $3.40 million -14.4%N/A723 $47.00 7/15/202484,500 shares $4.07 million -8.9%N/A0 $48.15 6/30/202492,800 shares $4.47 million +3.3%N/A0 $48.15 6/15/202489,800 shares $4.32 million +19.9%N/A0 $48.15 5/31/202474,900 shares $3.61 million -9.1%N/A749 $48.15 5/15/202482,400 shares $3.66 million -3.4%N/A0 $44.45 4/30/202485,300 shares $3.79 million -59.3%N/A0 $44.45 4/15/2024209,600 shares $9.32 million -6.5%N/A2096 $44.45 3/31/2024224,100 shares $9.13 million +0.6%N/A0 $40.75 3/15/2024222,800 shares $9.08 million +3.3%N/A0 $40.75 2/29/2024215,600 shares $8.79 million -14.3%N/A0 $40.75 2/15/2024251,600 shares $10.25 million -9.1%N/A2516 $40.75 1/15/2024268,800 shares $11.02 million +3.0%N/A0 $41.00 12/31/2023260,900 shares $10.70 million +1.5%N/A0 $41.00 12/15/2023257,100 shares $10.54 million +2.0%N/A0 $41.00 11/30/2023252,100 shares $10.34 million -1.9%N/A0 $41.00 11/15/2023256,900 shares $10.53 million -0.7%N/A0 $41.00 10/31/2023258,800 shares $10.61 million -9.0%N/A2588 $41.00 10/15/2023284,400 shares $14.22 million -1.4%N/A0 $50.00 9/30/2023288,300 shares $14.42 million +7.5%N/A0 $50.00 9/15/2023268,300 shares $13.42 million -2.9%N/A0 $50.00 8/31/2023276,400 shares $13.82 million -9.2%N/A0 $50.00 8/15/2023304,300 shares $15.22 million +2.6%N/A0 $50.00 7/31/2023296,600 shares $14.83 million -12.1%N/A0 $50.00Trump purposefully forcing markets to crash… (Ad)Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you ready for it?Click here to find out how to survive “Trump’s Reset” 7/15/2023337,300 shares $16.87 million -2.9%N/A0 $50.00 6/30/2023347,200 shares $17.36 million +4.0%N/A0 $50.00 6/15/2023333,900 shares $16.70 million -1.6%N/A3339 $50.00 5/31/2023339,200 shares $16.96 million +0.6%N/A3392 $50.00 5/15/2023337,300 shares $17.54 million -14.7%N/A3373 $52.00 4/30/2023395,600 shares $20.57 million +0.4%N/A0 $52.00 4/15/2023394,000 shares $20.49 million +0.5%N/A0 $52.00 3/31/2023392,200 shares $20.39 million +5.5%N/A0 $52.00 3/15/2023371,700 shares $19.33 million +0.5%N/A0 $52.00 2/28/2023369,700 shares $19.22 million -4.5%N/A0 $52.00 2/15/2023386,900 shares $20.12 million +3.6%N/A0 $52.00 1/31/2023373,400 shares $19.42 million +1.3%N/A0 $52.00 1/15/2023368,800 shares $19.18 million -0.1%N/A0 $52.00 12/30/2022369,000 shares $19.19 million +0.2%N/A0 $52.00 12/15/2022368,300 shares $19.15 million -0.9%N/A0 $52.00 11/30/2022371,800 shares $19.33 million -2.2%N/A3718 $52.00 11/15/2022380,200 shares $17.49 million -0.1%N/A3802 $46.00 10/31/2022380,600 shares $15.60 million -3.7%N/A0 $41.00 10/15/2022395,100 shares $16.20 million -2.7%N/A0 $41.00 9/30/2022406,100 shares $16.65 million +0.5%N/A0 $41.00 9/15/2022404,200 shares $16.57 million +6.2%N/A4042 $41.00 8/31/2022380,700 shares $15.61 million -5.5%N/A0 $41.00 8/15/2022402,900 shares $16.52 million -21.8%N/A0 $41.00 7/31/2022515,400 shares $21.13 million -19.0%N/A0 $41.00 7/15/2022635,900 shares $26.07 million -1.9%N/A0 $41.00 6/30/2022648,000 shares $26.57 million -1.3%N/A0 $41.00 6/15/2022656,300 shares $26.91 million -2.0%N/A0 $41.00 5/31/2022669,900 shares $27.47 million -0.6%N/A0 $41.00 5/15/2022673,600 shares $27.62 million -0.3%N/A0 $41.00 4/30/2022675,600 shares $27.70 million +2.3%N/A0 $41.00 4/15/2022660,500 shares $27.08 million +4.2%N/A0 $41.00 3/31/2022634,000 shares $25.99 million -2.3%N/A0 $41.00 3/15/2022649,000 shares $26.61 million -1.2%N/A0 $41.00 2/28/2022656,900 shares $26.93 million +4.5%N/A0 $41.00 2/15/2022628,900 shares $25.78 million +0.5%N/A6289 $41.00 1/31/2022625,900 shares $25.66 million -1.2%N/A0 $41.00 1/15/2022633,200 shares $25.96 million -1.1%N/A0 $41.00 12/31/2021640,000 shares $26.24 million -2.8%N/A0 $41.00 12/15/2021658,300 shares $26.99 million +0.6%N/A6583 $41.00 11/30/2021654,300 shares $30.75 million +1.8%N/A0 $47.00 11/15/2021642,500 shares $30.20 million +17.1%N/A0 $47.00 10/29/2021548,700 shares $25.79 million +8.0%N/A0 $47.00 10/15/2021508,100 shares $23.88 million +0.8%N/A5081 $47.00 9/30/2021504,000 shares $23.18 million +5.1%N/A0 $46.00 9/15/2021479,400 shares $22.05 million -3.3%N/A0 $46.00 8/31/2021495,700 shares $22.80 million -4.1%N/A0 $46.00 8/13/2021516,600 shares $23.76 million -2.7%N/A0 $46.00 7/30/2021530,800 shares $24.42 million -6.3%N/A5308 $46.00 7/15/2021566,400 shares $28.21 million -1.7%N/A0 $49.80 6/30/2021576,400 shares $28.71 million -1.1%N/A5764 $49.80Trump purposefully forcing markets to crash… (Ad)Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you ready for it?Click here to find out how to survive “Trump’s Reset” 6/15/2021582,600 shares $26.82 million -2.5%N/A0 $46.04 5/28/2021597,800 shares $27.52 million +0.7%N/A0 $46.04 5/14/2021593,500 shares $26.74 million -1.1%N/A5935 $45.05 4/30/2021600,100 shares $31.14 million -0.6%N/A6001 $51.89 4/15/2021603,400 shares $30.29 million -2.6%N/A6034 $50.20 3/31/2021619,400 shares $30.85 million -0.9%N/A6194 $49.80 3/15/2021625,200 shares $31.99 million +10.1%N/A6252 $51.16 2/26/2021567,800 shares $32.93 million +1.7%N/A5678 $58.00 2/12/2021558,100 shares $33.21 million +0.9%N/A0 $59.50 1/29/2021553,100 shares $32.91 million +0.9%N/A0 $59.50 1/15/2021550,300 shares $32.17 million -1.9%N/A5503 $58.46 12/31/2020548,800 shares $33.11 million -0.3%N/A5488 $60.34 12/15/2020550,300 shares $32.63 million -1.9%N/A5503 $59.30 11/30/2020560,800 shares $33.31 million -2.9%N/A5608 $59.40 11/15/2020577,400 shares $31.18 million +2.0%N/A0 $54.00 10/30/2020566,000 shares $30.56 million +13.8%N/A5660 $54.00 10/15/2020497,200 shares $27.15 million -4.9%N/A4972 $54.60 9/30/2020522,600 shares $29.01 million -1.3%N/A0 $55.52 9/15/2020529,300 shares $29.39 million -1.0%N/A5293 $55.52 8/31/2020534,500 shares $29.68 million -2.5%N/A2672.5 $55.52 8/14/2020548,300 shares $30.41 million +5.9%N/A0 $55.47 7/31/2020517,800 shares $28.88 million +64.0%N/A0 $55.77 7/15/2020315,800 shares $17.61 million +0.9%N/A3158 $55.77 6/30/2020313,000 shares $15.89 million -1.2%N/A3130 $50.78 6/15/2020316,700 shares $16.66 million -1.6%N/A0 $52.60 5/29/2020321,700 shares $15.96 million -16.7%N/A3217 $49.60 5/15/2020386,400 shares $19.52 million -1.5%N/A0 $50.51 4/30/2020392,100 shares $19.80 million +4.1%N/A3921 $50.51 BPMUF Short Interest - Frequently Asked Questions What is Basilea Pharmaceutica's current short interest? Short interest is the volume of Basilea Pharmaceutica shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 100 shares of BPMUF short. 0.00% of Basilea Pharmaceutica's shares are currently sold short. Learn More on Basilea Pharmaceutica's current short interest. What is a good short interest ratio for Basilea Pharmaceutica? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BPMUF shares currently have a short interest ratio of 1.0. Learn More on Basilea Pharmaceutica's short interest ratio. What is a good short interest percentage for Basilea Pharmaceutica? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Basilea Pharmaceutica's floating shares are currently sold short. Is Basilea Pharmaceutica's short interest increasing or decreasing? Basilea Pharmaceutica saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 100 shares, a decline of 95.2% from the previous total of 2,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Basilea Pharmaceutica's short interest compare to its competitors? 0.00% of Basilea Pharmaceutica's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Basilea Pharmaceutica: Immunovant, Inc. (28.85%), Alvotech (0.59%), ACADIA Pharmaceuticals Inc. (13.09%), MoonLake Immunotherapeutics (12.03%), HUTCHMED (China) Limited (0.21%), Apellis Pharmaceuticals, Inc. (19.42%), Amneal Pharmaceuticals, Inc. (3.22%), Recursion Pharmaceuticals, Inc. (28.93%), Twist Bioscience Co. (16.58%), ImmunityBio, Inc. (54.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Basilea Pharmaceutica stock? Short selling BPMUF is an investing strategy that aims to generate trading profit from Basilea Pharmaceutica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Basilea Pharmaceutica? A short squeeze for Basilea Pharmaceutica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPMUF, which in turn drives the price of the stock up even further. How often is Basilea Pharmaceutica's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPMUF, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies IMVT Short Interest ALVO Short Interest ACAD Short Interest MLTX Short Interest HCM Short Interest APLS Short Interest AMRX Short Interest RXRX Short Interest TWST Short Interest IBRX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BPMUF) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basilea Pharmaceutica AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Basilea Pharmaceutica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPMUF Stock Free BPMUF Stock Alerts